liz: russell flannery, the shanghai bureau chief for forbes. thank you for the insight. >> thanks for having us. liz: i think. we are hearing from russell, they have plans. they plan to dig their heels in against the united states. we will be watching it because it affects your money and our markets. let's look at cvs earnings. success reveals which direction drug prices are moving and it might not make people happy. with the closing bell ringing in 41 minutes, cvs is among the s&p 500 leaders gaining 7% in this final hour. yes, they beat second quarter earnings estimates. they raised full year guidance but here's why. the health care giant says increased prescription drug prices are helping to funnel money to its pharmacies benefit business. cvs needs more vitamins to erase what is still an 11% loss year to date though. >>> up next, new rules in new york city. you would think they hurt the ride hailing industry. our all-star panel here on whether it truly threatens to put a dent in lyft and uber profits down the road. "the claman countdown" is